Literature DB >> 24060581

Sphingolipids in colon cancer.

Mónica García-Barros1, Nicolas Coant2, Jean-Philip Truman3, Ashley J Snider4, Yusuf A Hannun5.   

Abstract

Colorectal cancer is one of the major causes of death in the western world. Despite increasing knowledge of the molecular signaling pathways implicated in colon cancer, therapeutic outcomes are still only moderately successful. Sphingolipids, a family of N-acyl linked lipids, have not only structural functions but are also implicated in important biological functions. Ceramide, sphingosine and sphingosine-1-phosphate are the most important bioactive lipids, and they regulate several key cellular functions. Accumulating evidence suggests that many cancers present alterations in sphingolipids and their metabolizing enzymes. The aim of this review is to discuss the emerging roles of sphingolipids, both endogenous and dietary, in colon cancer and the interaction of sphingolipids with WNT/β-catenin pathway, one of the most important signaling cascades that regulate development and homeostasis in intestine. This article is part of a Special Issue entitled New Frontiers in Sphingolipid Biology.
© 2013.

Entities:  

Keywords:  Ceramide; Colorectal cancer; Dietary; Sphingolipids; Sphingosine; Sphingosine-1-phosphate

Mesh:

Substances:

Year:  2013        PMID: 24060581      PMCID: PMC3962523          DOI: 10.1016/j.bbalip.2013.09.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  125 in total

1.  Evidence for specific ceramidase present in the intestinal contents of rats and humans.

Authors:  R D Duan; Y Cheng; L Yang; L Ohlsson; A Nilsson
Journal:  Lipids       Date:  2001-08       Impact factor: 1.880

Review 2.  A systematic review and meta-analysis of familial colorectal cancer risk.

Authors:  L E Johns; R S Houlston
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

3.  Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts.

Authors:  David E Modrak; Marisol D Rodriguez; David M Goldenberg; Walter Lew; Rosalyn D Blumenthal
Journal:  Int J Oncol       Date:  2002-02       Impact factor: 5.650

4.  Ceramide involvement in homocamptothecin- and camptothecin-induced cytotoxicity and apoptosis in colon HT29 cells.

Authors:  David Chauvier; Hamid Morjani; Michel Manfait
Journal:  Int J Oncol       Date:  2002-04       Impact factor: 5.650

5.  Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells.

Authors:  Eun Hyun Ahn; Joseph J Schroeder
Journal:  Exp Biol Med (Maywood)       Date:  2002-05

6.  Glucosylceramide synthesis and synthase expression protect against ceramide-induced stress.

Authors:  Yoshikazu Uchida; Satoru Murata; Matthias Schmuth; Martin J Behne; Jeong Deuk Lee; Shinichi Ichikawa; Peter M Elias; Yoshio Hirabayashi; Walter M Holleran
Journal:  J Lipid Res       Date:  2002-08       Impact factor: 5.922

7.  Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-alpha-mediated apoptosis in human colon HT-29 cells through glycosphingolipids formation. Possible role of ganglioside GD3.

Authors:  Anna Colell; Albert Morales; José C Fernández-Checa; Carmen García-Ruiz
Journal:  FEBS Lett       Date:  2002-08-28       Impact factor: 4.124

8.  Glycotherapy for cancer: remodeling of ganglioside pattern as an effective approach for cancer therapy.

Authors:  Hisao Nojiri; Hideaki Yamana; Genzan Shirouzu; Toshihide Suzuki; Hideo Isono
Journal:  Cancer Detect Prev       Date:  2002

9.  Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity.

Authors:  Urban Sjöqvist; Erik Hertervig; Ake Nilsson; Rui-Dong Duan; Ake Ost; Bernhard Tribukait; Robert Löfberg
Journal:  Inflamm Bowel Dis       Date:  2002-07       Impact factor: 5.325

10.  Sphingosine-1-phosphate stimulates human Caco-2 intestinal epithelial proliferation via p38 activation and activates ERK by an independent mechanism.

Authors:  Vijayalakshmi Thamilselvan; Wei Li; Bauer E Sumpio; Marc D Basson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-04       Impact factor: 2.416

View more
  27 in total

1.  LPS receptor subunits have antagonistic roles in epithelial apoptosis and colonic carcinogenesis.

Authors:  W-T Kuo; T-C Lee; H-Y Yang; C-Y Chen; Y-C Au; Y-Z Lu; L-L Wu; S-C Wei; Y-H Ni; B-R Lin; Y Chen; Y-H Tsai; J T Kung; F Sheu; L-W Lin; L C-H Yu
Journal:  Cell Death Differ       Date:  2015-01-30       Impact factor: 15.828

2.  Fecal metabolomics: assay performance and association with colorectal cancer.

Authors:  James J Goedert; Joshua N Sampson; Steven C Moore; Qian Xiao; Xiaoqin Xiong; Richard B Hayes; Jiyoung Ahn; Jianxin Shi; Rashmi Sinha
Journal:  Carcinogenesis       Date:  2014-07-18       Impact factor: 4.944

3.  Liver serine palmitoyltransferase activity deficiency in early life impairs adherens junctions and promotes tumorigenesis.

Authors:  Zhiqiang Li; Inamul Kabir; Hui Jiang; Hongwen Zhou; Jenny Libien; Jianying Zeng; Albert Stanek; Peiqi Ou; Kailyn R Li; Shane Zhang; Hai H Bui; Ming-Shang Kuo; Tae-Sik Park; Benjamin Kim; Tilla S Worgall; Chongmin Huan; Xian-Cheng Jiang
Journal:  Hepatology       Date:  2016-12       Impact factor: 17.425

4.  De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer.

Authors:  Naser Jafari; James Drury; Andrew J Morris; Fredrick O Onono; Payton D Stevens; Tianyan Gao; Jinpeng Liu; Chi Wang; Eun Y Lee; Heidi L Weiss; B Mark Evers; Yekaterina Y Zaytseva
Journal:  Mol Cancer Res       Date:  2018-08-28       Impact factor: 5.852

5.  Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice.

Authors:  Liansheng Zhong; Ji Na Kong; Michael B Dinkins; Silvia Leanhart; Zhihui Zhu; Stefka D Spassieva; Haiyan Qin; Hsuan-Pei Lin; Ahmed Elsherbini; Rebecca Wang; Xue Jiang; Mariana Nikolova-Karakashian; Guanghu Wang; Erhard Bieberich
Journal:  J Lipid Res       Date:  2018-03-22       Impact factor: 5.922

6.  Role of neutral ceramidase in colon cancer.

Authors:  Mónica García-Barros; Nicolas Coant; Toshihiko Kawamori; Masayuki Wada; Ashley J Snider; Jean-Philip Truman; Bill X Wu; Hideki Furuya; Christopher J Clarke; Agnieszka B Bialkowska; Amr Ghaleb; Vincent W Yang; Lina M Obeid; Yusuf A Hannun
Journal:  FASEB J       Date:  2016-09-08       Impact factor: 5.191

7.  A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer.

Authors:  James P Madigan; Robert W Robey; Joanna E Poprawski; Huakang Huang; Christopher J Clarke; Michael M Gottesman; Myles C Cabot; Daniel W Rosenberg
Journal:  Exp Cell Res       Date:  2020-01-20       Impact factor: 3.905

Review 8.  Lipid mechanisms in hallmarks of cancer.

Authors:  J Molendijk; H Robinson; Z Djuric; M M Hill
Journal:  Mol Omics       Date:  2020-02-17

9.  Glucosylceramide production maintains colon integrity in response to Bacteroides fragilis toxin-induced colon epithelial cell signaling.

Authors:  Logan Patterson; Jawara Allen; Isabella Posey; Jeremy Joseph Porter Shaw; Pedro Costa-Pinheiro; Susan J Walker; Alexis Gademsey; Xinqun Wu; Shaoguang Wu; Nicholas C Zachos; Todd E Fox; Cynthia L Sears; Mark Kester
Journal:  FASEB J       Date:  2020-10-13       Impact factor: 5.834

10.  Identification of Small-Molecule Inhibitors of Neutral Ceramidase (nCDase) via Target-Based High-Throughput Screening.

Authors:  Yuka Otsuka; Michael V Airola; Yong-Mi Choi; Nicolas Coant; Justin Snider; Chris Cariello; Essa M Saied; Christoph Arenz; Thomas Bannister; Ron Rahaim; Yusuf A Hannun; Justin Shumate; Louis Scampavia; John D Haley; Timothy P Spicer
Journal:  SLAS Discov       Date:  2020-07-31       Impact factor: 3.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.